Reevaluating Beta-Blocker Use in Heart Attack Patients: Benefits and Risks
TL;DR
Two recent trials on beta-blockers in post-MI patients with preserved or mildly reduced ejection fraction show mixed results, but meta-analyses suggest potential benefits for those with ejection fraction between 40% and 49%. This challenges the routine use of beta-blockers in all post-MI patients and advocates for a more personalized approach based on ejection fraction and individual risk factors.
- Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF TCTMD.com
- Common heart attack drug doesn’t work and may raise risk of death for some women, new studies say CNN
- Does a common heart attack pill help everyone? Studies disagree Reuters
- Doctors may need to rethink decades of routine beta blocker use for some patients after a heart attack, studies suggest ABC News
- Common heart attack drug could have fatal consequences for women, study finds The Independent
Want the full story? Read the original reporting
Read on TCTMD.com